13 Jun CardiAQ Valve Technologies v. Neovasc 

June 10, 2016 BOSTON, MA – After a 3-week trial in the U.S. District Court of Massachusetts, a jury panel decided in favor of CardiAQ Valve Technologies, Inc., a subsidiary of Edwards Life Sciences.  CardiAQ was awarded $70 million as a result of Neovasc, Inc.’s misappropriation...